Description

Protein C is a vitamin K-dependent plasma glycoprotein that plays a crucial role in regulating blood coagulation. It is synthesized in the liver and, when activated (activated Protein C or APC), exerts anticoagulant effects by inactivating factors Va and VIIIa, thereby preventing excessive clot formation. A functional Protein C assay measures the activity of Protein C in the blood to determine its ability to regulate coagulation properly.

Protein C, Functional Assay

Test Purpose:

• To diagnose Protein C deficiency, which can lead to an increased risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE).
• To evaluate unexplained blood clotting disorders.
• To monitor patients with known Protein C deficiency.

Sample Collection and Preparation:

1. Specimen Type: Plasma.
2. Collection Tube: Blood is collected in a tube containing citrate as an anticoagulant.
3. Collection Procedure:
   • A healthcare provider draws blood from a vein, typically in the arm.
   • The blood is immediately transferred into the citrate tube and mixed gently to prevent clotting.
   • The sample is then centrifuged to separate plasma from blood cells.

Normal Reference Range:

• Adult Normal Range: Typically, 70-140% of normal activity, but this can vary depending on the laboratory and the specific assay used.

Interpretation of Results:

• Normal Protein C Activity: Indicates that Protein C is functioning properly, and there is no deficiency.
• Reduced Protein C Activity:
  • Mild to Moderate Deficiency: May be associated with a higher risk of venous thrombosis. It can be inherited or acquired.
  • Severe Deficiency: Often leads to a higher risk of thrombotic events and can present as neonatal purpura fulminans, a severe, life-threatening condition in newborns.

Clinical Significance:

• Protein C Deficiency:
  • Inherited Protein C Deficiency: An autosomal dominant disorder that increases the risk of developing blood clots. It can be heterozygous (one copy of the defective gene) or homozygous (two copies of the defective gene), with homozygous cases being more severe.
  • Acquired Protein C Deficiency: Can result from conditions such as liver disease, vitamin K deficiency, disseminated intravascular coagulation (DIC), or the use of certain medications (e.g., warfarin).
• Venous Thromboembolism (VTE): Patients with Protein C deficiency are at an increased risk for VTE, including DVT and PE. The functional assay helps assess the risk and guide treatment decisions.

Follow-Up and Treatment:

• Further Testing: If Protein C deficiency is suspected, additional tests such as genetic testing, measurement of Protein S (a cofactor for Protein C), and a complete evaluation of the coagulation system may be recommended.
• Anticoagulant Therapy: Patients with Protein C deficiency and a history of thrombotic events may require long-term anticoagulant therapy (e.g., warfarin, direct oral anticoagulants) to prevent recurrence.
• Lifestyle Modifications: Patients may be advised to adopt lifestyle changes to reduce the risk of thrombosis, such as maintaining a healthy weight, staying active, and avoiding prolonged immobility.

Special Considerations:

• Warfarin Use: Warfarin, a common anticoagulant, can lower Protein C levels, so testing should be done before starting warfarin therapy or after a washout period.
• Liver Function: Since Protein C is synthesized in the liver, liver disease can affect its levels and function.

The functional Protein C assay is a valuable tool for diagnosing and managing coagulation disorders, particularly those related to Protein C deficiency. It provides crucial information for risk assessment and therapeutic decision-making in patients prone to thrombotic events.